Akanda Corp. Announces Registered Direct Offering
Akanda Corp. (NASDAQ: 
AKAN), an international medical cannabis company, has recently disclosed its participation in a registered direct offering priced at the Minimum Price under Nasdaq rules. The company has entered into a securities purchase agreement with an accredited investor for the acquisition of 2,491,381 common shares at a purchase price of $0.1031. Additionally, the investor will obtain 21,756,922 pre-funded warrants to purchase 21,756,922 common shares at $0.103 per share.
The pre-funded warrants are immediately exercisable at an exercise price of $0.0001 and are subject to certain beneficial ownership limitations as outlined in the pre-funded warrant.
Technical Outlook
Akanda Corp. (NASDAQ:AKAN) stock is up 24.98% as of the time of writing with a bullish Relative Strength Index (RSI) of 66.87 which is slightly overbought. The stock has risen from a falling wedge pattern.
AKAN), an international medical cannabis company, has recently disclosed its participation in a registered direct offering priced at the Minimum Price under Nasdaq rules. The company has entered into a securities purchase agreement with an accredited investor for the acquisition of 2,491,381 common shares at a purchase price of $0.1031. Additionally, the investor will obtain 21,756,922 pre-funded warrants to purchase 21,756,922 common shares at $0.103 per share. The pre-funded warrants are immediately exercisable at an exercise price of $0.0001 and are subject to certain beneficial ownership limitations as outlined in the pre-funded warrant.
Technical Outlook
Akanda Corp. (NASDAQ:
AKAN) stock is up 24.98% as of the time of writing with a bullish Relative Strength Index (RSI) of 66.87 which is slightly overbought. The stock has risen from a falling wedge pattern.
⭐⭐⭐ Sign Up for Free ⭐⭐⭐
1) Download our Mobile App >> link-to.app/dexwirenews
2) Join our Telegram >> t.me/DEXWireNews
3) Sign Up for Text Alerts >>
dexwirenews.com/TEXT
4) Follow @DEXWireNews on Social Media
1) Download our Mobile App >> link-to.app/dexwirenews
2) Join our Telegram >> t.me/DEXWireNews
3) Sign Up for Text Alerts >>
dexwirenews.com/TEXT
4) Follow @DEXWireNews on Social Media
Aviso legal
As informações e publicações não devem ser e não constituem conselhos ou recomendações financeiras, de investimento, de negociação ou de qualquer outro tipo, fornecidas ou endossadas pela TradingView. Leia mais em Termos de uso.